CoChat

AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques

Open access
Montero-Benitez, Maria Zhao, Carmona-Llanos, Alba, Fernández-Jiménez, Rocio, Román-Jobacho, Alicia, Gómez-Millán, Jaime, Modamio-Molina, Javier, Cabrera-Cesar, Eva, Vegas-Aguilar, Isabel, Amaya-Campos, Maria del Mar, Tinahones, Francisco J., Molina-Montes, Esther, Cayón-Blanco, Manuel, García-Almeida, Jose Manuel · 2025 · Cancers

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index; none of the 57 sources its claims cite is checked for support yet.

Abstract

Background: Sarcopenia and low muscle mass are prevalent and prognostically relevant in patients with lung cancer, yet their diagnosis remains challenging in routine clinical practice. Opportunistic assessment using computed tomography (CT) has emerged as a valuable tool for body composition evaluation. We aimed to assess the utility of thoracic CT at T12 and T4 levels in identifying sarcopenia and low muscle mass and explore their correlation with morphofunctional tools such as bioelectrical impedance vector analysis (BIVA), nutritional ultrasound (NU), and functional performance tests. Methods: In this prospective observational study, 80 patients with lung cancer were evaluated at diagnosis. Body composition was assessed using BIVA-, NU-, and CT-derived parameters at T12 and T4 levels. Functional status was measured using the Timed Up and Go (TUG) and 30-Second Chair Stand Test. Sarcopenia was defined according to EWGSOP2 criteria. Results: Sarcopenia was identified in 20% of patients. CT-derived indices at T12CT demonstrated better diagnostic performance than T4CT. For detecting low muscle mass, the optimal SMI cut-off values were SMI_T12CT < 31.98 cm2/m2 and SMI_T4CT < 59.05 cm2/m2 in men and SMI_T12CT < 28.23 cm2/m2 and SMI_T4CT < 41.69 cm2/m2 in women. For sarcopenia diagnosis, the values were SMI_T12CT < 24.78 cm2/m2 and SMI_T4CT < 57.23 cm2/m2 in men and SMI_T12CT < 21.24 cm2/m2 and SMI_T4CT < 49.35 cm2/m2 in women. A combined model including SMI_T12CT, RF_CSA, and the 30 s squat test showed high diagnostic accuracy (AUC = 0.826). In multivariable analysis, lower SMA_T12CT was independently associated with risk of sarcopenia (OR = 0.96, 95% CI: 0.92–0.99, p = 0.022), as were older age (OR = 1.23, 95% CI: 1.07–1.47, p = 0.010) and fewer repetitions in the 30 s squat test (OR = 0.78, 95% CI: 0.63–0.91, p = 0.007). Conclusions: CT-derived body composition assessment, particularly at the T12 level, shows good correlation with morphofunctional tools and may offer a reliable and timely alternative for identifying sarcopenia and low muscle mass in patients with lung cancer.

Overview

CoChat Summary

TL;DR

In 80 patients with lung cancer, CT-derived body composition at T12 performed better than T4 for identifying low muscle mass and sarcopenia, with sarcopenia found in 20% by EWGSOP2 criteria. A combined model using SMI_T12CT, rectus femoris cross-sectional area, and the 30 s squat test achieved good diagnostic accuracy (AUC = 0.826).

Key findings

  • Sarcopenia was identified in 20% of patients; 53.8% had low muscle mass when combining low ASMM and/or low ASMI.
  • T12CT showed better diagnostic performance than T4CT: for low muscle mass, optimal SMI cut-offs were SMI_T12CT < 31.98 cm²/m² and SMI_T4CT < 59.05 cm²/m² in men, and SMI_T12CT < 28.23 cm²/m² and SMI_T4CT < 41.69 cm²/m² in women.
  • For sarcopenia diagnosis, cut-offs were SMI_T12CT < 24.78 cm²/m² and SMI_T4CT < 57.23 cm²/m² in men, and SMI_T12CT < 21.24 cm²/m² and SMI_T4CT < 49.35 cm²/m² in women.
  • In multivariable analysis, lower SMA_T12CT (OR = 0.96, 95% CI: 0.92–0.99, p = 0.022), older age (OR = 1.23, 95% CI: 1.07–1.47, p = 0.010), and fewer 30 s squat repetitions (OR = 0.78, 95% CI: 0.63–0.91, p = 0.007) were independently associated with sarcopenia.

Methods

  • Prospective, observational, single-centre study of 80 patients with lung cancer evaluated at diagnosis at the Endocrinology and Nutrition Unit of Virgen de la Victoria University Hospital.
  • Body composition was assessed using BIVA, nutritional ultrasound, and CT-derived parameters at T12 and T4 levels via FocusedON® software; functional status used handgrip strength, Timed Up and Go, and 30-Second Chair Stand Test; sarcopenia was defined by EWGSOP2 criteria.
  • Analysis included ROC curves with Youden index for cut-offs, correlation analyses, and multivariable logistic regression for sarcopenia predictors.

Limitations

  • The paper states small sample size and limited number of sarcopenic patients may reduce statistical power and generalizability; single-centre design may restrict external validity; cohort was predominantly male, limiting applicability to female populations.
  • The paper also notes lack of standardized reference values for thoracic CT-defined sarcopenia, modest AUC values and variability in sensitivity/specificity, and that FocusedON® remains an emerging methodology requiring further validation; residual confounding is possible.
  • Evident from the text: the study reports no external validation cohort and no longitudinal outcome data, so clinical utility for predicting outcomes is not established here.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/cancers17193255

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Heatmap of correlation between sarcopenia and morphofunctional variables including CT, HGS, NU and BIVA. Abbreviations: SMI: Skeletal muscle index by BIVA; BCM: Body cell mass; RF_CSA: Rectus femoris cross-sectional area (ultrasound); RF_Y_axis: rectus femoris Y-axis (vertical diameter); HGS: Handgrip strength; SMI_T4CT: Skeletal muscle index at the T4 level by computed tomography; SMI_T12CT: Skeletal muscle index at the T12 level by computed tomography.
Figure 1 Heatmap of correlation between sarcopenia and morphofunctional variables including CT, HGS, NU and BIVA. Abbreviations: SMI: Skeletal muscle index by BIVA; BCM: Body cell mass; RF_CSA: Rectus femoris cross-sectional area (ultrasound); RF_Y_axis: rectus femoris Y-axis (vertical diameter); HGS: Handgrip strength; SMI_T4CT: Skeletal muscle index at the T4 level by computed tomography; SMI_T12CT: Skeletal muscle index at the T12 level by computed tomography.CC BY · PubMed Central
Figure 2 Heatmap of correlation between CT-derived adipose tissue parameters and morphofunctional fat-related variables. Abbreviations: FMI: Fat Mass Index; L-SAT: Lateral Subcutaneous Adipose Tissue (ultrasound); T-SAT: Total Subcutaneous Adipose Tissue (ultrasound); SAT: Subcutaneous Adipose Tissue (CT); VAT: Visceral Adipose Tissue (CT); IMAT: Intramuscular Adipose Tissue (CT).
Figure 2 Heatmap of correlation between CT-derived adipose tissue parameters and morphofunctional fat-related variables. Abbreviations: FMI: Fat Mass Index; L-SAT: Lateral Subcutaneous Adipose Tissue (ultrasound); T-SAT: Total Subcutaneous Adipose Tissue (ultrasound); SAT: Subcutaneous Adipose Tissue (CT); VAT: Visceral Adipose Tissue (CT); IMAT: Intramuscular Adipose Tissue (CT).CC BY · PubMed Central
Figure 3 (a,b). ROC cut-off point for low muscle mass at T4 and T12 in lung cancer patients. Figure (a) corresponds to men and Figure (b) to women. Abbreviations: SMA_T12CT: skeletal muscle area at T12 level; SMI_T12CT: skeletal muscle index at T12 level; SMA_T4CT: skeletal muscle area at T4 level; SMI_T4CT: skeletal muscle index at T4 level.
Figure 3 (a,b). ROC cut-off point for low muscle mass at T4 and T12 in lung cancer patients. Figure (a) corresponds to men and Figure (b) to women. Abbreviations: SMA_T12CT: skeletal muscle area at T12 level; SMI_T12CT: skeletal muscle index at T12 level; SMA_T4CT: skeletal muscle area at T4 level; SMI_T4CT: skeletal muscle index at T4 level.CC BY · PubMed Central
Figure 4 (a,b). ROC cut-off points for sarcopenia (EWGSOP2) at T4 and T12 levels in lung cancer patients. Figure (a) corresponds to men and Figure (b) to women. Abbreviations: SMA_T4CT: skeletal muscle area at T4 level by CT; SMA_T12CT: skeletal muscle area at T12 level by CT; SMI_T4CT: skeletal muscle index at T4 level by CT; SMI_T12CT: skeletal muscle index at T12 level by CT; AUC: area under the curve; PPV: positive predictive value; NPV: negative predictive value.
Figure 4 (a,b). ROC cut-off points for sarcopenia (EWGSOP2) at T4 and T12 levels in lung cancer patients. Figure (a) corresponds to men and Figure (b) to women. Abbreviations: SMA_T4CT: skeletal muscle area at T4 level by CT; SMA_T12CT: skeletal muscle area at T12 level by CT; SMI_T4CT: skeletal muscle index at T4 level by CT; SMI_T12CT: skeletal muscle index at T12 level by CT; AUC: area under the curve; PPV: positive predictive value; NPV: negative predictive value.CC BY · PubMed Central
Figure 5 ROC curve for the multimodal model combining SMA_T12CT, RF_CSA, and 30 s squat test for sarcopenia detection. Abbreviations: SMI_T12CT: skeletal muscle index at T12 level by CT; RF_CSA: rectus femoris cross-sectional area (ultrasound); 30 s squat test: 30-second squat test; AUC: area under the curve; PPV: positive predictive value; NPV: negative predictive value.
Figure 5 ROC curve for the multimodal model combining SMA_T12CT, RF_CSA, and 30 s squat test for sarcopenia detection. Abbreviations: SMI_T12CT: skeletal muscle index at T12 level by CT; RF_CSA: rectus femoris cross-sectional area (ultrasound); 30 s squat test: 30-second squat test; AUC: area under the curve; PPV: positive predictive value; NPV: negative predictive value.CC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 20 Not checked · 121 Own results and interpretations

89 more claims

Create a free account to see all 141 claims and to verify the 57 references still open.

See all claims — free account
  • It may state two separate claims as one. 36
  • The quote only partly states this claim. 1
  • Probably not a substantial claim. 18

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 44 references

Cited by

See all 7

Metadata

Authors
Montero-Benitez, M. Z., Carmona-Llanos, A., Fernández-Jiménez, R., Román-Jobacho, A., Gómez-Millán, J., Modamio-Molina, J., Cabrera-Cesar, E., Vegas-Aguilar, I., Amaya-Campos, M. D. M., Tinahones, F. J., Molina-Montes, E., Cayón-Blanco, M., & García-Almeida, J. M.
Affiliations
  • Departament of Endocrinology and Nutrition, Jerez Universitary Hospital, 11407 Jerez de la Frontera, Spain
  • Departament of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, 29010 Málaga, Spain
  • Department of Radiación Oncology, Virgen de la Victoria University Hospital, 29010 Málaga, Spain
  • Instituto de Investigación Biomédica y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29590 Málaga, Spain
  • Hospital Universitario del Sureste (ES)
  • Department of Neumology, Virgen de la Victoria University Hospital, 29010 Málaga, Spain
  • Andalusian Centre for Nanomedicine and Biotechnology (ES)
  • Instituto de Salud Carlos III (ES)
  • Departament of Nutrition and Food Sciencie, University of Granada, 18071 Granada, Spain
  • Hospital Universitario de Jerez (ES)
Venue
Cancers
Publisher
MDPI AG
Published
2025-10-08
Volume
17
Issue
19
Pages
3255
ISSN
2072-6694 (ISSN-L)
OpenAlex
W4414930279
Cited by
7
References
44
Citations by year
2026: 6 · 2025: 1
FWCI
3.01
Type
journal article
Language
en
Open access
Locations
  • Cancers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
Keywords
sarcopenia, lung cancer, body composition, skeletal muscle index, bioelectrical impedance vector analysis, functional performance, Timed Up and Go test, 30-second chair stand test, EWGSOP2 criteria, sarcopenia risk factors, prognostic factors, low muscle mass

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques. https://app.cochat.ai/papers/10.3390/cancers17193255
The paper
Montero-Benitez, M. Z., Carmona-Llanos, A., Fernández-Jiménez, R., Román-Jobacho, A., Gómez-Millán, J., Modamio-Molina, J., Cabrera-Cesar, E., Vegas-Aguilar, I., Amaya-Campos, M. D. M., Tinahones, F. J., Molina-Montes, E., Cayón-Blanco, M., & García-Almeida, J. M. (2025). AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques. Cancers. https://doi.org/10.3390/cancers17193255

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.